STERO Biotechs
Manufacturing · Israel · 1-10 Employees
View Company Info for Free
Overview
Headquarters
14-18 Baruch Hirsh, Bene Beraq, Tel Aviv...Website
www.sterobiotechs.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About STERO Biotechs
STERO Biotechs Ltd is a clinical-stage company based in Israel, focused on developing novel Cannabidiol (CBD)-based treatments aimed at reducing the need for steroid therapy and minimizing associated side effects. The company has shown promising results in a phase 2 clinical trial for Graft Versus Host Disease (GVHD), demonstrating that CBD can enhance steroid effectiveness or reduce dosage. Their patented technology covers the use of CBD for treating inflammatory and autoimmune diseases, potentially benefiting millions of patients. Established in 2017, STERO Biotechs collaborates with the technology transfer unit of Israel's largest HMO, CLALIT Health Services.Explore more
STERO Biotechs Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is STERO Biotechs your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once STERO Biotechs has new funding data
Product Launch: Get notified when STERO Biotechs launches new products
Congratulate Masked Content for being promoted to Masked Content at STERO Biotechs
Earning: See what the market has to say on STERO Biotechs recently announced quarterly report
STERO Biotechs, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if STERO Biotechs is spiking on competitors!
Click to see if STERO Biotechs had a recent Job posting/layoffs
Check if STERO Biotechs has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at STERO Biotechs
Find 3 more new buyers
Company Profile Activity
Activity Insights
STERO Biotechs is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
STERO Biotechs is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about STERO Biotechs.
STERO Biotechs Tech Stack
A closer look at the technologies used by STERO Biotechs
STERO Biotechs News & Media
Stero Biotechs supports an Exploratory Study of CBD-based treatment for COVID-19 severe patients
TEL AVIV, Israel, Jan. 5, 2021 /PRNewswire/ -- Stero Biotechs, an Israel-based, clinical-stage company focused on Cannabidiol (CBD) formulation research and development, is proud to supply and support a clinical trial, covered by its' IP for Cannabidiol Treatment of Severe and Critical...Stero Biotechs Announces First Patient in Phase 2A Clinical Trial for CBD Effects on Chronic Spontaneous Urticaria
A placebo-controlled, single-center study conducted to evaluate tolerability, safety, efficacy, and steroid-sparing effect of CBD in CSU patients. TEL AVIV, ISRAEL, August 5, 2020 /EINPresswire.com/ -- Stero Biotechs Ltd., an Israel-based, clinical- …Stero Biotechs Announce an IP Protected Clinical Trial for COVID-19 Patients Using a CBD-Steroid Treatment
TEL AVIV, Israel, April 20, 2020 /PRNewswire/ -- Stero Biotechs, an Israel-based, clinical-stage company focused on Cannabidiol (CBD) formulation research and development, in a collaboration with its main partner and shareholder, Mor Research Applications, the Tech Transfer Office (TTO)...Kalytera and Stero Biotechs Will Not Proceed with Acquisition
SAN FRANCISCO, April 13, 2020 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") has announced that it will not proceed with the previously announced acquisition of Stero Biotechs, Ltd. (“Stero”), and that Stero and Kalytera have terminated the Letter of Intent relating to the acquisition.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding STERO Biotechs
Sign Up For FreeTo access detailed company insights
STERO Biotechs Ltd is a clinical-stage company based in Israel, focused on developing novel Cannabidiol (CBD)-based treatments aimed at reducing the need for steroid therapy and minimizing associated side effects. The company has shown promising results in a phase 2 clinical trial for Graft Versus Host Disease (GVHD), demonstrating that CBD can enh... Read More
